Cargando…
Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213593/ https://www.ncbi.nlm.nih.gov/pubmed/37237409 http://dx.doi.org/10.1186/s12967-023-04186-4 |
| _version_ | 1785047656052031488 |
|---|---|
| author | Liu, Dongsheng Saeed, Aamir Majaz, Sidra Ahmad, Bashrat Ahmad, Ashfaq Xie, Yingqiu |
| author_facet | Liu, Dongsheng Saeed, Aamir Majaz, Sidra Ahmad, Bashrat Ahmad, Ashfaq Xie, Yingqiu |
| author_sort | Liu, Dongsheng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10213593 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102135932023-05-27 Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent Liu, Dongsheng Saeed, Aamir Majaz, Sidra Ahmad, Bashrat Ahmad, Ashfaq Xie, Yingqiu J Transl Med Letter to the Editor BioMed Central 2023-05-26 /pmc/articles/PMC10213593/ /pubmed/37237409 http://dx.doi.org/10.1186/s12967-023-04186-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Letter to the Editor Liu, Dongsheng Saeed, Aamir Majaz, Sidra Ahmad, Bashrat Ahmad, Ashfaq Xie, Yingqiu Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent |
| title | Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent |
| title_full | Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent |
| title_fullStr | Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent |
| title_full_unstemmed | Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent |
| title_short | Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent |
| title_sort | targeting severe symptoms of early 2023-new outbreak of covid-19 by classical drug dexamethasone: a potential fatality reducing agent |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213593/ https://www.ncbi.nlm.nih.gov/pubmed/37237409 http://dx.doi.org/10.1186/s12967-023-04186-4 |
| work_keys_str_mv | AT liudongsheng targetingseveresymptomsofearly2023newoutbreakofcovid19byclassicaldrugdexamethasoneapotentialfatalityreducingagent AT saeedaamir targetingseveresymptomsofearly2023newoutbreakofcovid19byclassicaldrugdexamethasoneapotentialfatalityreducingagent AT majazsidra targetingseveresymptomsofearly2023newoutbreakofcovid19byclassicaldrugdexamethasoneapotentialfatalityreducingagent AT ahmadbashrat targetingseveresymptomsofearly2023newoutbreakofcovid19byclassicaldrugdexamethasoneapotentialfatalityreducingagent AT ahmadashfaq targetingseveresymptomsofearly2023newoutbreakofcovid19byclassicaldrugdexamethasoneapotentialfatalityreducingagent AT xieyingqiu targetingseveresymptomsofearly2023newoutbreakofcovid19byclassicaldrugdexamethasoneapotentialfatalityreducingagent |